How Stress Alters Opioid Drug Effects
NCT06485817 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2024-07-05
Summary
The main objective of the study is to test the hypothesis that opioid drug effects vary as a function of pre-drug affective state. Specifically, it is hypothesized that social stress induction enhances opioid drug wanting compared a non-stress control condition.
Conditions
- Motivation
- Drug Effect
- Stress Reaction
- Misuse, Opioid
Interventions
- DRUG
-
Oxycodone
3.1mg oxycodone/70 kg body weight was administered as the main drug intervention. Based on body weight, the study nurse/anesthetist adjusted the (unknown) content in two syringes by removing enough fluid to reach a volume that would result in a dose equivalent of 3.1mg/70kg (0,043 mg/ml pr kg) should the syringes contain oxycodone. The first dose was administered 5 minutes after the state induction task. The second dose was adjusted according to the performance on the self-administration task (but maximum 100% of the first dose) and administered 45 later.
- DRUG
-
Pure saline was administered as the placebo condition. Based on body weight, the study nurse/anesthetist adjusted the (unknown) content in two syringes by removing enough fluid to reach a volume that would result in a dose equivalent of 3.1mg/70kg (0,043 mg/ml pr kg) should the syringes contain oxycodone. The first dose was administered 5 minutes after the state induction task. The second dose was adjusted according to the performance on the self-administration task (but maximum 100% of the first dose) and administered 45 later.
- BEHAVIORAL
-
Stress State Induction
ReSST is an in-house hybrid online-lab implementation of two stress induction paradigms based on the Trier Social stress test (TSST) and Iowa Social Singing Stress Test (I-SSST). The set-up was tailored to allow repeated stress induction without diminishing effects that allowed for an online experiment panel. Stress and control state inductions were administered every-other session. The singing version of the stress test was always administered last as it was deemed more stressful during piloting.
- BEHAVIORAL
-
Control State Induction
Two different control tasks matched to the stress conditions on key parameters outlined in the protocol.
Sponsors & Collaborators
-
Oslo University Hospital
collaborator OTHER -
Linkoeping University
collaborator OTHER_GOV -
University of Oslo
lead OTHER
Principal Investigators
-
Siri Leknes, PhD · University of Oslo
-
Marie Eikemo, PhD · University of Oslo
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-15
- Primary Completion
- 2022-04-28
- Completion
- 2022-04-28
Countries
- Norway
Study Locations
More Related Trials
-
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
NCT03143855 ·Status: COMPLETED ·Phase: PHASE1
-
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684 ·Status: COMPLETED ·Phase: NA
-
Influence of Medication on Functional Connectivity
NCT03612713 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences
NCT03335085 ·Status: COMPLETED ·Phase: NA
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
NCT03773523 ·Status: RECRUITING ·Phase: NA
-
Ovarian Hormones and Stress Induced Drug Craving
NCT02098434 ·Status: COMPLETED ·Phase: NA
-
Dose-dependent Effects of Oxytocin on the Amygdala and Reward System
NCT03846739 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Oxytocin on Stress in Marijuana Users
NCT01335789 ·Status: COMPLETED ·Phase: NA
-
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
NCT03854942 ·Status: TERMINATED ·Phase: PHASE1
-
The Influence of Oxytocin on Automatic Imitation Behaviour in Healthy Adults
NCT01767025 ·Status: COMPLETED ·Phase: PHASE3
-
Individual Differences in the Response to Drugs
NCT02485158 ·Status: COMPLETED ·Phase: NA
-
The Human Stress Response in a Simulated ED Setting
NCT04317482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Oxytocin and Social Behavior Over the Lifespan
NCT00914953 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prevalence of New Psychoactive Substances Use
NCT03695419 ·Status: UNKNOWN
-
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255 ·Status: COMPLETED ·Phase: PHASE2
-
Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents
NCT04336605 ·Status: UNKNOWN
-
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin, Trauma Disclosure and Intrusions
NCT03425929 ·Status: COMPLETED ·Phase: PHASE1
-
Neuropharmacological Basis of Social Connection: The Role of Opioids
NCT01672723 ·Status: COMPLETED ·Phase: NA
-
Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II
NCT02652195 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Fruit Smoothie Supplementation on Psychological Distress Among People Receiving Opioid Agonist Therapy
NCT05229770 ·Status: COMPLETED ·Phase: NA
-
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT00184184 ·Status: COMPLETED
-
The Discriminative Effects of Tramadol in Humans
NCT00499746 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oxytocin and the Processing of Social Stress-Associated Chemosignals
NCT03265899 ·Status: COMPLETED ·Phase: PHASE1